3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
2
Completed
2
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urologic Neoplasms
1
Urinary Incontinence
1
Testicular Neoplasms
1
Prostatic Neoplasms
1
Penile Neoplasms
1
Neoplasms
1
Kidney Neoplasms
1
Interventions
enzalutamide
33
Abiraterone Acetate
29
apalutamide
26
Prednisone
26
Radiotherapy
25
Magnetic Resonance Spectroscopy
25
Androgen Antagonists
24
Leuprolide
22
Radiosurgery
19
darolutamide
18
Docetaxel
17
Gonadotropin-Releasing Hormone
16
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
15
Goserelin
13
gallium 68 PSMA-11
12
bicalutamide
12
Specimen Handling
12
Radiotherapy, Intensity-Modulated
12
abiraterone
11
Radiation
11
pembrolizumab
10
Pluvicto
10
Carboplatin
9
Brachytherapy
9
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
9
relugolix
8
luprolide acetate gel depot
8
Triptorelin Pamoate
8
Standard of Care
8
Nivolumab
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Prostatic Neoplasms
×
Physical Therapy Modalities
×
Clear all
NCT05946993
2026-05-01
LIAM Mc
University College Cork
Phase NA
Active not recruiting
72 enrolled